Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.03% | 11.78% | 13.74% | 12.58% | 9.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.03% | 11.78% | 13.74% | 12.58% | 9.38% |
| Cost of Revenue | 10.70% | 11.52% | 12.94% | 12.26% | 9.36% |
| Gross Profit | 11.69% | 12.30% | 15.37% | 13.24% | 9.41% |
| SG&A Expenses | 11.21% | 10.92% | 12.49% | 12.81% | 8.45% |
| Depreciation & Amortization | 10.95% | 21.26% | 31.62% | 31.25% | 23.42% |
| Other Operating Expenses | -50.00% | 200.00% | 350.00% | -- | 300.00% |
| Total Operating Expenses | 10.79% | 11.57% | 13.20% | 12.67% | 9.41% |
| Operating Income | 12.43% | 13.06% | 17.01% | 12.06% | 9.17% |
| Income Before Tax | 15.65% | 13.90% | 16.92% | 13.62% | 5.75% |
| Income Tax Expenses | 23.68% | 15.02% | 22.86% | 16.53% | 6.83% |
| Earnings from Continuing Operations | 13.40% | 13.57% | 15.28% | 12.81% | 5.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | -8.00% | -16.33% | -8.00% | 3.77% |
| Net Income | 14.16% | 13.89% | 15.22% | 13.10% | 6.03% |
| EBIT | 12.43% | 13.06% | 17.01% | 12.06% | 9.17% |
| EBITDA | 12.22% | 13.72% | 17.76% | 14.02% | 10.73% |
| EPS Basic | 14.34% | 13.81% | 14.87% | 13.00% | 6.43% |
| Normalized Basic EPS | 14.07% | 12.30% | 11.63% | 7.69% | 4.42% |
| EPS Diluted | 14.20% | 13.57% | 15.74% | 13.90% | 7.63% |
| Normalized Diluted EPS | 14.31% | 12.33% | 11.18% | 7.48% | 4.45% |
| Average Basic Shares Outstanding | 0.00% | 0.22% | 0.00% | 0.00% | -0.45% |
| Average Diluted Shares Outstanding | -0.22% | 0.22% | 0.44% | 0.22% | -0.44% |
| Dividend Per Share | 6.89% | 6.67% | 6.42% | 6.16% | 5.90% |
| Payout Ratio | -0.07% | -0.06% | -0.08% | -0.06% | -0.01% |